The global spread of COVID-19 pandemic has significantly influenced medical and healthcare domain, where our main business is deployed at, and currently there are many uncertain factors that could have an impact on business performance. For this reason, it is extremely difficult to calculate appropriate and rational forecasts of business results at this time. We have judged that announcing the new Medium-Term Business Plan under these conditions could cause confusion among shareholders and investors. Accordingly, we have decided to postpone the announcement of the new Medium-Term Business Plan, which was originally scheduled to be announced on May 13, 2020.

We will continue to examine medium-term business outlook by taking post COVID-19 pandemic business environment into consideration, and promptly announce our new Medium-Term Business Plan as soon as we have finalized the plan.